viernes, 27 de septiembre de 2013

DOD Mefloquine Policy Mirrors FDA Update on Malaria Drug

DOD Mefloquine Policy Mirrors FDA Update on Malaria Drug



DOD Mefloquine Policy Mirrors FDA Update on Malaria Drug


Press Releases for Military Health System.



09/26/2013 02:37 PM EDT



The Defense Department’s policy on the antimalarial drug mefloquine, which has been in use for decades, is consistent with a stronger, updated warning about the drug from the Food and Drug Administration, senior DOD officials said.


No hay comentarios:

Publicar un comentario